IP Library Granted Patent US 8,871,444
Granted Patent B2
US 8,871,444 · App. 13/693,356 · Granted Oct 28, 2014

In vitro evolution in microfluidic systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,444
App. No.
13/693,356
Granted
Oct 28, 2014
Kind
B2
Abstract

The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalizing genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.

Claims (13)

1. A method for detecting a product of an enzymatic reaction, comprising the steps of:

providing a droplet generator to produce, under microfluidic control, a plurality of aqueous microcapsules surrounded by an immiscible continuous phase that comprises a fluorinated oil that comprises a fluorinated polymer surfactant, each of the plurality of microcapsules comprising an enzyme, a genetic element, and reagents for the enzymatic reaction;

pooling the microcapsules into one or more common compartments such that a portion of the plurality of microcapsules contact each other but do not fuse with each other due to the presence of the surfactant;

conducting the enzymatic reaction on the genetic element of at least one of the plurality of microcapsules within the one or more common compartments; and

detecting the product of the enzymatic reaction.

2. The method of claim 1 , wherein the genetic elements are nucleic acids, proteins, or cells.

3. The method of claim 2 , wherein the nucleic acids are primers for a polymerase chain reaction (PCR).

4. The method of claim 1 , wherein the genetic elements are labeled.

5. The method of claim 4 , wherein the genetic elements are optically labeled.

6. The method of claim 4 , wherein the genetic elements are fluorescently labeled antibodies.

7. The method of claim 4 , wherein the genetic elements are chemically labeled antibodies.

8. The method of claim 1 , wherein the microcapsules are monodisperse with respect to each other.

9. The method of claim 1 , wherein the droplet generator further comprises an aqueous fluid channel and two immiscible continuous phase channels and producing the plurality of microcapsules surrounded by the immiscible continuous phase under the microfluidic control comprises partitioning an aqueous fluid that is flowing through the aqueous fluid channel with two counter propagating streams of the immiscible continuous phase that are flowing through the immiscible continuous phase channels.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2013
From: LINK, DARREN; AHN, KEUNHO; WEITZ, DAVID; BIBETTE, JEROME
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 030214/0993 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2013
From: GRIFFITHS, ANDREW
To: MEDICAL RESEARCH COUNCIL
Reel/Frame 030215/0021 →